Trump
Top Ten most popular articles on Pharmafile.com this week
July 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Pfizer, Sanofi, Trump, top 10
In the week leading up to Donald Trump’s visit to the United Kingdom, the news has been dominated by the …
Trump forces Pfizer to back down and delay price hikes until 2019
July 11, 2018Research and Development, Sales and Marketing Alex Azar, Donald Trump, Ian Read, Pfizer, President trump, Trump, druig pricing, pharma
Trump bared his teeth, and it paid off. Following his call-out of Pfizer after the US pharma giant ignored the …
Trump slams Pfizer over price hikes, Pfizer responds
July 10, 2018Manufacturing and Production, Sales and Marketing Donald Trump, Drug pricing, Pfizer, Trump, pharma
Price hiking in the pharmaceutical industry continues to persist, and has become ever more prominent in the public sphere thanks …
Unfazed by Trump, Pfizer hikes prices for 100 of its drugs
July 3, 2018Manufacturing and Production, Sales and Marketing Pfizer, President trump, Trump, pharma, price hikes
After a campaign full of not-so-veiled threats directed at the pharma industry, and a presidency which has so far failed …
The June 2018 issue of Pharmafocus is now live!
May 31, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Ebola, GDPR, Trump, UK, brexit, data managment, market access, pharma
The new June edition of Pharmafocus is now available to read online.
Top Ten most popular articles on Pharmafile.com this week
May 18, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, Novartis, Takeda, Trump, brexit, pharma, pharmafile, top ten
The year is flying by – it’s another Friday, and that means another Top Ten run-down.Perhaps the biggest story this …
Novartis’ top lawyer retires from role over botched Trump deal
May 16, 2018Medical Communications, Research and Development Michael Cohen, Novartis, Trump, pharma
The saga of Novartis’ ill-advised $1.2 million deal with US President Donald Trump’s lawyer Michael Cohen continues to unfold as …
Novartis’ $1.2m payment to Trump’s lawyer raises more questions than answers
May 10, 2018Medical Communications Essential Consultants, Michael Cohen, Novartis, President trump, Trump, biotech, drugs, pharma, pharmaceutical
Novartis payment to President Trump’s personal lawyer, Michael Cohen, had seemed fairly odd from the beginning – with many asking …
Novartis caught in the Stormy Daniels affair, after huge payment to Trump’s lawyer
May 9, 2018Medical Communications, Research and Development Cohen, Novartis, President trump, Trump, biotech, drugs, pharma, pharmaceutical
Novartis has suddenly found itself embroiled in the Stormy Daniels affair, after the lawyer representing her, Michael Avenatti, included the …
Top Ten most popular articles on Pharmafile.com this week
February 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's disease, Roche, Top 10 news, Top ten news, Trump, biotech, drugs, pharma, pharmaceutical
Another week is finished and it’s been a disastrous one for research into a potential treatment for Alzheimer’s disease. Two of …
Trump’s drug pricing reforms lack bite
February 12, 2018Sales and Marketing Drug pricing, President trump, Trump, biotech, drugs, pharma, pharmaceutical
President Trump’s rhetoric leading up to his election had the pharmaceutical industry very worried – his often quoted line about …
Trump nominee and ex-Lilly exec confirmed as US Health Secretary by Senate
January 25, 2018Manufacturing and Production, Medical Communications, Sales and Marketing Alex Azar, Eli Lilly, President trump, Trump, US, pharma
Alex Azar, President’s Trump’s controversial pick for Health and Human Services Secretary (HHS), has been confirmed in the role after …
Proposed cuts to National Institutes of Health could delay up to 90% of US drug approvals
November 27, 2017Research and Development, Sales and Marketing Donald Trump, FDA, NIH, National Institutes of Health, Trump, pharma
President Donald Trump’s budget proposes to cut funding to the National Institutes of Health by $7.2 billion or 21%. Researchers …
Budget cuts to the President’s Malaria Initiative could risk 67 million lives, report finds
November 22, 2017Medical Communications, Research and Development Africa, Trump, USA, WHO, malaria, pharma
A team of researchers at Imperial College London (ICL) has argued that the proposal by US Congress to cut the …
Indivior’s opioid addiction treatment recommended by FDA advisory panel
November 1, 2017Research and Development, Sales and Marketing FDA, RGP-6000, Trump, US, indivior, opioid crisis, opioids
Another step has been made in the fight back against the ongoing opioid crisis in the US as it emerges …
Latest content
Five Facts about cardiovascular disease
